Paloma Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,049
| Closed | -$1.43M | – | 1359 |
|
|
2024
Q1 | $1.43M | Sell |
9,049
-66,351
| -88% | -$10.6M | 0.08% | 278 |
|
|
2023
Q4 | $11.8M | Buy |
75,400
+70,400
| +1,408% | +$10.8M | 0.43% | 33 |
|
|
2023
Q3 | $779K | Buy |
+5,000
| New | +$825K | 0.03% | 412 |
|
|
2023
Q2 | – | Sell |
-50,000
| Closed | -$7.75M | – | 855 |
|
|
2023
Q1 | $7.75M | Buy |
+50,000
| New | +$8.07M | 0.27% | 54 |
|
|
2022
Q3 | – | Sell |
-4,100
| Closed | -$728K | – | 1179 |
|
|
2022
Q2 | $728K | Buy |
+4,100
| New | +$731K | 0.03% | 525 |
|
|
2022
Q1 | – | Sell |
-90,200
| Closed | -$15.4M | – | 2005 |
|
|
2021
Q4 | $15.4M | Buy |
+90,200
| New | +$14.8M | 0.23% | 48 |
|
|
2021
Q3 | – | Sell |
-18,900
| Closed | -$3.11M | – | 1497 |
|
|
2021
Q2 | $3.11M | Buy |
+18,900
| New | +$3.13M | 0.06% | 301 |
|
|
2020
Q3 | – | Sell |
-8,300
| Closed | -$1.17M | – | 2273 |
|
|
2020
Q2 | $1.17M | Buy |
+8,300
| New | +$1.21M | 0.02% | 856 |
|
|
2019
Q2 | – | Sell |
-12,000
| Closed | -$1.68M | – | 1973 |
|
|
2019
Q1 | $1.68M | Buy |
+12,000
| New | +$1.61M | 0.04% | 511 |
|
|
2018
Q4 | – | Sell |
-58,900
| Closed | -$8.14M | – | 1524 |
|
|
2018
Q3 | $8.14M | Buy |
58,900
+24,000
| +69% | +$3.19M | 0.15% | 98 |
|
|
2018
Q2 | $4.24M | Buy |
+34,900
| New | +$4.35M | 0.08% | 211 |
|
|
2018
Q1 | – | Sell |
-13,900
| Closed | -$1.94M | – | 2105 |
|
|
2017
Q4 | $1.94M | Sell |
13,900
-18,000
| -56% | -$2.51M | 0.03% | 682 |
|
|
2017
Q3 | $4.15M | Buy |
+31,900
| New | +$4.23M | 0.06% | 346 |
|
|
2017
Q2 | – | Sell |
-129,400
| Closed | -$16.1M | – | 2309 |
|
|
2017
Q1 | $16.1M | Buy |
129,400
+96,200
| +290% | +$11.5M | 0.19% | 71 |
|
|
2016
Q4 | $3.83M | Sell |
33,200
-123,700
| -79% | -$14.3M | 0.04% | 351 |
|
|
2016
Q3 | $18.5M | Buy |
156,900
+132,900
| +554% | +$16.1M | 0.23% | 64 |
|
|
2016
Q2 | $2.91M | Buy |
+24,000
| New | +$2.73M | 0.03% | 483 |
|
|
2016
Q1 | – | Sell |
-2,000
| Closed | -$205K | – | 1957 |
|
|
2015
Q4 | $205K | Buy |
+2,000
| New | +$201K | 0.01% | 1544 |
|
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$201K | – | 1859 |
|
|
2015
Q1 | $201K | Hold |
2,000
| – | – | 0.01% | 1083 |
|
|
2014
Q4 | $209K | Hold |
2,000
| – | – | 0.01% | 990 |
|
|
2014
Q3 | $213K | Sell |
2,000
-14,000
| -88% | -$1.45M | 0.01% | 830 |
|
|
2014
Q2 | $1.67M | Buy |
+16,000
| New | +$1.62M | 0.07% | 260 |
|
Other funds holding JNJ
Paloma Partners's JNJ Position: Q4 2024 in Review
Paloma Partners sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,439 shares — an estimated $233K sold.
Paloma Partners first reported a position in JNJ in Q2 2013 and held it in 36 quarters. The position peaked at $32.5M in Q2 2020. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Paloma Partners reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 1,439 Johnson & Johnson shares in Q4 2024, an estimated $233K.
- Paloma Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 36 quarters.
- Paloma Partners's Johnson & Johnson position peaked at $32.5M in Q2 2020.
- 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.